Most Recent
Regeneron steps up opposition to Kymab’s human rat patent
Intellectual Property August 26, 2019 12:47 pm By Cat Fredenburgh

US biotechnology company Regeneron Pharmaceuticals has filed a Federal Court challenge after losing its opposition to a patent application by UK biopharmaceutical company Kymab for […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

Regeneron loses opposition to Kymab’s patent for human rats
Intellectual Property August 1, 2019 2:30 pm By Miklos Bolza

US biotechnology firm Regeneron Pharmaceuticals has lost its opposition to a proposed patent by UK biopharmaceutical company Kymab for a method of producing an animal […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

Boehringer wins time to oppose Intervet patent after lawyers botched deadline
Intellectual Property July 22, 2019 4:56 pm By Cat Fredenburgh

A unit of Boehringer Ingelheim has been given more time to oppose a proposed patent by rival drug maker Intervet, after the German drug company’s […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

Bayer faces appeals of IP Australia rulings on antiseptic patent
Intellectual Property June 4, 2019 3:24 pm By Miklos Bolza

Veterinary pharmaceutical companies Norbrook Laboratories and Merial have launched twin appeals of two IP Australia decisions allowing Bayer to amend a proposed patent for a […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

Juno Pharmaceuticals settles trade mark dispute with Juno Therapeutics
Intellectual Property January 25, 2019 3:42 pm By Miklos Bolza

Juno Pharmaceuticals has resolved its appeal of an IP Australia ruling that allowed Seattle-based Juno Therapeutics to extend protection of its namesake trade mark into […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

CSIRO appeals ruling allowing changes to BASF GMO patent
Intellectual Property January 29, 2019 3:12 pm By Miklos Bolza

The CSIRO is appealing a decision by the Commissioner of Patents that allowed chemical giant BASF to amend its application for a genetically modified organisms […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

Ramsay Health Care’s Nuramel trade mark beats off challenge
Intellectual Property December 6, 2018 1:49 pm By Christine Caulfield

Ramsay Health Care has defeated a challenge to its Nuramel trade mark for a brand of infant formula, with IP Australia saying while the mark […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

GSK defeats challenge to breakthrough RSV vaccine patent
Intellectual Property November 26, 2018 9:39 pm By Cat Fredenburgh

GlaxoSmithKline has won approval for a patent for a vaccine to prevent a common respiratory virus affecting infants, beating out a challenge from a rival […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

Merial takes fight over Intervet parasite patent to federal court
Intellectual Property September 12, 2018 11:11 pm By Cat Fredenburgh

Animal drug giant Merial is pushing on with its opposition to rival Intervet’s bid to a patent a non-drug resistant injectable formula for treating animal […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.